Antibody patterns in blood may help identify people at risk of IBD
Scientists found the immune system leaves warning signs up to a decade before diagnosis of Crohn's disease and ulcerative colitis.

Antibody patterns in the blood may help doctors identify people at risk of inflammatory bowel disease (IBD) so they can be treated earlier. Scientists found the immune system sends warning signals up to a decade before diagnosis, paving the way for potentially earlier detection and even prevention.
Researchers at the University Medical Centre Groningen, the Icahn School of Medicine at Mount Sinai, and the Medical University of Vienna examined 2,000 blood samples from 500 people. Among these, 200 people later developed Crohn's disease and 200 developed ulcerative colitis, while 100 developed neither condition.
In those who later developed Crohn's disease, antibodies against Epstein-Barr virus were more common, and these differences were visible a decade before diagnosis. The signal was strongest in those who later developed more severe, complicated disease. People who developed ulcerative colitis showed a different pattern, including antibodies against one of the body's own proteins.
“For too long we have only been able to treat inflammatory bowel disease once the damage is done, and for many people that is too late,” said Dr Arno Bourgonje at the University Medical Centre Groningen and the Icahn School of Medicine at Mount Sinai. He added that the disease begins years before symptoms appear and the immune system leaves warning signs long before diagnosis.
At least 3.8 million people worldwide live with IBD, an immune condition that drives chronic inflammation of the digestive tract, causing pain, diarrhoea and fatigue. Crohn's disease and ulcerative colitis, the two main forms of IBD, are typically treated only after symptoms appear, when the gut has already been damaged.
The findings, published in the journal Gut and presented at the United European Gastroenterology meeting in Barcelona, show a link rather than proving infections cause IBD.
Key facts
- The immune system sends warning signals up to a decade before an IBD diagnosis.
- Antibodies against Epstein-Barr virus were more common in those who later developed Crohn's disease.
- At least 3.8 million people worldwide live with IBD.
Three perspectives
Neutral
The study identified antibody patterns in blood samples that correlate with the later development of Crohn's disease and ulcerative colitis.
Positive
The research offers a potential path toward identifying people at risk before damage begins, similar to how blood tests identify type 1 diabetes.
Negative
Crohn's disease and ulcerative colitis are typically treated only after symptoms appear, when the gut has already been damaged.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.
